Journal of Participatory Medicine

Co-production in research and healthcare, technology for patient empowerment and fostering partnership with clinicians.

Editor-in-Chief:

Amy Price, DPhil, Senior Research Scientist, The Dartmouth Institute for Health Policy and Clinical Practice Geisel School of Medicine, Dartmouth College, USA


CiteScore 3.1

The JMIR Journal of Participatory Medicine is the leading peer-reviewed journal dedicated to advancing and disseminating science on the meaningful participation of individuals in research and care delivery, and the use of technology for patient and citizen empowerment. 

Articles focus on co-production and participatory design in research and healthcare, developing and deploying technology for patient self-care, fostering patient-clinician partnerships, improving patient and caregiver experience, and citizen science.

The journal is fully open access, supporting a global community of scientists, educators, clinicians, advocates, patients, and the public. We publish original research, reviews, viewpoints, case studies, and essays including those written by patients and caregivers. Extraordinary Lives articles highlight individuals the world has lost who served as exemplars of participatory medicine.

The journal is also the official journal of the Society for Participatory Medicine

The Journal of Participatory Medicine features a rapid and thorough peer-review process, professional copyediting, professional production of PDF, XHTML, and XML proofs (deposited in PubMed/PubMed Central). The Journal adheres to the same quality standards as all JMIR publications. 

All articles published here are also cross-listed in the Table of Contents of JMIR, the world's leading medical journal in health sciences / health services research and health informatics. 

The journal is indexed in Sherpa Romeo, DOAJ, PubMed, PubMed Central, Scopus, and EBSCO. 

There are no publishing charges for unfunded research. There is a modest Article Processing Fee ($1500) in case of acceptance for grant-funded research or where authors have access to institutional open access funds, e.g., COMPACT/COPE signatories. 


With a CiteScore of 3.1 (2024), The Journal of Participatory Medicine is a Q2 journal in the field of Medicine (miscellaneous), according to Scopus data.

 



Recent Articles

Article Thumbnail
Theme Issue (2024): Patient and Consumer Use of Artificial Intelligence for Health

Preventing diabetes is a priority for governments and health systems worldwide. Artificial Intelligence (AI) has the potential to inform prevention and planning. But there is little guidance on how patients, caregivers, and communities are engaged in the AI lifecycle stages.

|
Article Thumbnail
Patient and Public Involvement in Research

Patient engagement in research is the meaningful and active involvement of patient/caregiver partners (i.e., patients and their family/friends) in research priority-setting, conduct, and governance. With the proper support, patient/caregiver partners can inform every stage of the research cycle, but common barriers often prevent their full engagement.

|
Article Thumbnail
Theme Issue (2024): Patient and Consumer Use of Artificial Intelligence for Health

The adoption of artificial intelligence (AI) in health care has outpaced education of the clinical workforce on responsible use of AI in patient care. Although many policy statements advocate safe, ethical, and trustworthy AI, guidance on the use of health AI has rarely included patient perspectives. This gap leaves out a valuable source of information and guidance about what responsible AI means to patients. In this viewpoint coauthored by patients, students, and faculty, we discuss a novel approach to integrating patient perspectives in undergraduate premedical education in the United States that aims to foster an inclusive and patient-centered future of AI in health care.

|
Article Thumbnail
Patient and Public Involvement in Research

Public deliberation is a qualitative research method that has successfully been used to solicit lay people’s perspectives on health ethics topics, but questions remain as to whether this traditionally in-person method translates into the online context. The MindKind Study conducted public deliberation sessions to gauge the concerns and aspirations of young people in India, South Africa, and the United Kingdom in regard to a prospective mental health databank. This paper details our adaptations to and evaluation of the public deliberation method in the online context, especially in the presence of a digital divide.

|
Article Thumbnail
Theme Issue (2024): Patient and Consumer Use of Artificial Intelligence for Health

Waiting has become an unfortunate reality for parents seeking care for their child in the emergency department (ED). Long wait times are known to increase morbidity and mortality. Providing patients with information about their wait time increases satisfaction and sense of control. There are very few patient-facing artificial intelligence (AI) tools currently in use in EDs, particularly tools that are co-designed with patients and caregivers.

|
Article Thumbnail
Patient and Public Involvement in Research

Infectious diseases disproportionately affect rural and ethnic communities in Colombia, where structural inequalities such as limited access to health care, poor sanitation, and scarce health education worsen their effects. Education is essential for preventing and controlling infectious diseases, fostering awareness of healthy behaviors, and empowering communities with the knowledge and skills to manage their health. Participatory and co-design methods strengthen educational programs by ensuring cultural relevance, enhancing knowledge retention, and promoting sustainable community interventions.

|
Article Thumbnail
Digital Therapeutics

Chronic health conditions (CHC) are a recognized risk factor for the experience of problems in sexual function (PSF). Only a subset develops severe symptoms of sexual distress, the defining criterion for clinically relevant sexual dysfunction (SD) according to the ICD-11. Data on the contribution of specific CHC to clinically relevant SD symptoms and related healthcare needs are limited, hindering targeted interventions.

|
Article Thumbnail
Shared Decision Making and Self-Advocacy

Launched in January 2022, the SingHealth Patient Advocacy Network @ Department of Medicine (SPAN@DEM) represents the first emergency department-specific advocacy group in Singapore. This initiative marks a significant advancement in local patient advocacy efforts because it employs a shared collaborative model to address the needs and concerns of patients within the unique context of the emergency department environment. SPAN@DEM emerged in recognition of the limitations of existing cluster-level advocacy groups, which are inadequate to address specific challenges inherent to the fast-paced, high-pressure nature of the emergency department.

|
Article Thumbnail
Co-Design & Participatory Design

Recommendations from professional bodies, including the Royal College of Psychiatrists, advise mental health practitioners to discuss problematic online use with children and young people. However, barriers such as knowledge gaps and low confidence in initiating discussions often prevent these conversations from happening.

|
Article Thumbnail
Patient Engagement and Empowerment

Engaging patients, care partners, and others in research planning and conduct is increasingly valued. However, identifying the most effective ways to do so remains a challenge.

|
Article Thumbnail
Theme Issue (2024): Patient and Consumer Use of Artificial Intelligence for Health

Artificial intelligence (AI) technology has made significant advancements in healthcare. A key application of using AI for health (AIH) is the use of AI-powered chatbots; however, empirical evidence on their effectiveness and feasibility remains limited.

|
Article Thumbnail
Theme Issue (2024): Patient and Consumer Use of Artificial Intelligence for Health

The use of artificial intelligence (AI) in healthcare has significant implications for patient-clinician interactions. Practical and ethical challenges have emerged with the adoption of large language models (LLMs) that respond to prompts from clinicians, patients and caregivers. With an emphasis on patient experience, this paper examines the potential of LLMs to act as facilitators, interrupters, or both in patient-clinician relationships. Drawing on our experiences as patient advocates, computer scientists, and physician informaticists working to improve data exchange and patient experience, we examine how LLMs might enhance patient engagement, support triage, and inform clinical decision-making. While affirming LLMs as a tool enabling the rise of the “AI patient,” we also explore concerns surrounding data privacy, algorithmic bias, moral injury, and the erosion of human connection. To help navigate these tensions, we outline a conceptual framework that anticipates the role and impact of LLMs in patient-clinician dynamics and propose key areas for future inquiry. Realizing the potential of LLMs requires careful consideration of which aspects of the patient-clinician relationship must remain distinctly human and why, even when LLMs offer plausible substitutes. This inquiry should draw on ethics and philosophy, aligned with AI imperatives such as patient-centered design and transparency, and shaped through collaboration between technologists, healthcare providers, and patient communities.

|

We are working in partnership with

  • Crossref Member
  • Open Access
  • Open Access Scholarly Publishers Association
  •  
  •  
  • TrendMD MemberORCID Member
  •  Society for Participatory Medicine

This journal is indexed in

  • PubMed
  • PubMed Central
  •  
  •  
  • DOAJDOAJ SealSherpa RomeoEBSCO/EBSCO Essentials

  •  
  •  
  •  

  •  
  •